These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 8788966
1. Effect of chronic treatment with trandolapril or enalapril on brain ACE activity in spontaneously hypertensive rats. Jouquey S, Mathieu MN, Hamon G, Chevillard C. Neuropharmacology; 1995 Dec; 34(12):1689-92. PubMed ID: 8788966 [Abstract] [Full Text] [Related]
2. Compared properties of trandolapril, enalapril, and their diacid metabolites. Chevillard C, Jouquey S, Bree F, Mathieu MN, Stepniewski JP, Tillement JP, Hamon G, Corvol P. J Cardiovasc Pharmacol; 1994 Dec; 23 Suppl 4():S11-5. PubMed ID: 7527095 [Abstract] [Full Text] [Related]
3. Trandolapril dose-response in spontaneously hypertensive rats: effects on ACE activity, blood pressure, and cardiac hypertrophy. Jouquey S, Stepniewski JP, Hamon G. J Cardiovasc Pharmacol; 1994 Dec; 23 Suppl 4():S16-8. PubMed ID: 7527096 [Abstract] [Full Text] [Related]
4. Effects of subchronic treatment with trandolapril and enalapril on cardiovascular morphologic alterations in the aged spontaneously hypertensive rat with heart failure. Secchi J, Lecaque D, Dunn FW, Jouquey S, Auberval UD, Benzoni F, Sirugue O, Hamon G. J Cardiovasc Pharmacol; 1994 Dec; 23 Suppl 4():S30-7. PubMed ID: 7527099 [Abstract] [Full Text] [Related]
5. Differential effects of oral trandolapril and enalapril on rat tissue angiotensin-converting enzyme. Chevillard C, Brown NL, Mathieu MN, Laliberté F, Worcel M. Eur J Pharmacol; 1988 Feb 16; 147(1):23-8. PubMed ID: 2836219 [Abstract] [Full Text] [Related]
6. Angiotensin-converting enzyme inhibition, anti-hypertensive activity and hemodynamic profile of trandolapril (RU 44570). Brown NL, Badel MY, Benzoni F, Zanirato J, Vincent JC, Fichelle J, Worcel M. Eur J Pharmacol; 1988 Mar 22; 148(1):79-91. PubMed ID: 3383998 [Abstract] [Full Text] [Related]
7. Cardiovascular actions and tissue-converting enzyme inhibitory effects of chronic enalapril and trandolapril treatment of spontaneously hypertensive rats. Chevillard C, Brown NL, Jouquey S, Mathieu MN, Laliberté F, Hamon G. J Cardiovasc Pharmacol; 1989 Aug 22; 14(2):297-301. PubMed ID: 2476605 [Abstract] [Full Text] [Related]
8. Inhibition of brain angiotensin-converting enzyme by peripheral administration of trandolapril versus lisinopril in Wistar rats. Tan J, Wang JM, Leenen FH. Am J Hypertens; 2005 Feb 22; 18(2 Pt 1):158-64. PubMed ID: 15752941 [Abstract] [Full Text] [Related]
9. Vascular affinity of trandolapril. Miyazaki M, Kawamoto T, Okunishi H. Am J Hypertens; 1995 Oct 22; 8(10 Pt 2):63S-67S. PubMed ID: 8845086 [Abstract] [Full Text] [Related]
10. Effects of enalapril on the expression of cardiac angiotensin-converting enzyme and angiotensin-converting enzyme 2 in spontaneously hypertensive rats. Yang Z, Yu X, Cheng L, Miao LY, Li HX, Han LH, Jiang WP. Arch Cardiovasc Dis; 2013 Apr 22; 106(4):196-201. PubMed ID: 23706365 [Abstract] [Full Text] [Related]
11. Comparison of the actions of the angiotensin-converting enzyme inhibitors enalapril and S-9490-3 in sodium-deplete and sodium-replete spontaneously hypertensive rats. DiNicolantonio R, Doyle AE. J Cardiovasc Pharmacol; 1985 Apr 22; 7(5):937-42. PubMed ID: 2413304 [Abstract] [Full Text] [Related]
12. Effects of candesartan cilexetil and enalapril on structural alterations and endothelial function in small resistance arteries of spontaneously hypertensive rats. Rizzoni D, Porteri E, Bettoni G, Piccoli A, Castellano M, Muiesan ML, Pasini G, Guelfi D, Rosei EA. J Cardiovasc Pharmacol; 1998 Nov 22; 32(5):798-806. PubMed ID: 9821855 [Abstract] [Full Text] [Related]
13. Significant target organs for hypertension and cardiac hypertrophy by angiotensin-converting enzyme inhibitors. Takai S, Jin D, Sakaguchi M, Miyazaki M. Hypertens Res; 2004 Mar 22; 27(3):213-9. PubMed ID: 15080380 [Abstract] [Full Text] [Related]
14. Molecular mechanism of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats. Makino N, Sugano M, Otsuka S, Hata T. Hypertension; 1997 Oct 22; 30(4):796-802. PubMed ID: 9336375 [Abstract] [Full Text] [Related]
15. Antinociceptive effects of angiotensin-converting enzyme inhibitors and an angiotensin II receptor antagonist in mice. Takai S, Song K, Tanaka T, Okunishi H, Miyazaki M. Life Sci; 1996 Oct 22; 59(21):PL331-6. PubMed ID: 8937511 [Abstract] [Full Text] [Related]
16. Steady-state pharmacokinetics and pharmacodynamics of imidaprilat, an active metabolite of imidapril, a new angiotensin-converting enzyme inhibitor in spontaneously hypertensive rats. Yamanaka K, Takehara N, Murata K, Banno K, Sato T. J Pharm Sci; 1996 Nov 22; 85(11):1234-7. PubMed ID: 8923331 [Abstract] [Full Text] [Related]
17. Moexipril, a new angiotensin-converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalapril. Edling O, Bao G, Feelisch M, Unger T, Gohlke P. J Pharmacol Exp Ther; 1995 Nov 22; 275(2):854-63. PubMed ID: 7473177 [Abstract] [Full Text] [Related]
18. Trandolapril reduces infarction area after middle cerebral artery occlusion in rats. Okamoto K, Takai S, Sasaki S, Miyazaki M. Hypertens Res; 2002 Jul 22; 25(4):583-8. PubMed ID: 12358145 [Abstract] [Full Text] [Related]
19. [Studies on angiotensin I converting enzyme (ACE): inhibitory effect of imidapril, a novel ACE inhibitor (II). Inhibition of various tissue ACEs ex vivo]. Hashimoto Y, Kubo M, Sugaya T, Minobe S, Watanabe T, Yamamura M, Matsuoka Y. Nihon Yakurigaku Zasshi; 1994 Jul 22; 104(1):51-61. PubMed ID: 8076891 [Abstract] [Full Text] [Related]
20. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure. Jorde UP, Vittorio TJ, Dimayuga CA, Homma S, Rizkala A, Le Jemtel TH, Katz SD. Am J Cardiol; 2004 Dec 15; 94(12):1501-5. PubMed ID: 15589004 [Abstract] [Full Text] [Related] Page: [Next] [New Search]